<unk>  is used in the treatment of benign prostatic hyperplasia (BPH) in Japan. It has been used at a dosage of 200 mg once every 2 weeks via intramuscular injection. Although it is approved for the treatment of BPH in Japan, concerns have been raised about its use for this condition due to poor efficacy seen in clinical trials.
Oxendolone
Oxymetholone
Metenolone
Trenbolone
Trestolone
Ganaxolone
Tibolone
Fluocinonide